(주)오리엔트바이오 · KOSPI: 002630 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩28.8B | ₩28.0B | ₩29.4B |
| Operating income | ₩1.5B | −₩646M | −₩3.1B |
| Net income | −₩12.4B | ₩12.9B | −₩13.2B |
| Total assets | ₩81.1B | ₩97.0B | ₩84.8B |
| Total liabilities | ₩9.7B | ₩11.9B | ₩12.9B |
| Total equity | ₩71.4B | ₩85.1B | ₩71.8B |
| Share capital | ₩59.3B | ₩59.3B | ₩59.3B |
Separate statements · FY2025 operating margin -10.5% · liabilities to equity 18% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 68 (current) | 성현회계법인 | Unqualified |
| Term 67 (prior) | 성현회계법인 | Unqualified |
| Term 66 (two years prior) | 회계법인리안 | Unqualified |
| Date | Largest shareholder (Korean) | Stake | Cause (Korean) |
|---|---|---|---|
| 2019년 02월 07일 | ㈜오리엔트 | — | 주주배정 유상증자 참여 |
| Date | Filing | Original |
|---|---|---|
| 2026-09-04 | Large shareholding (5%+) report | DART |
| 2026-09-04 | Officer / major shareholder ownership report | DART |
| 2026-08-14 | Quarterly report (2026.06) | DART |
| 2026-08-03 | Extraordinary shareholders meeting results | DART |
| 2026-07-23 | Large shareholding (5%+) report | DART |
| 2026-07-16 | Notice of shareholders meeting | DART |
| 2026-07-08 | Large shareholding (5%+) report | DART |
| 2026-06-29 | Independent director appointment / dismissal / resignation | DART |
| 2026-06-29 | Annual general meeting results | DART |
| 2026-06-24 | Amended: Officer / major shareholder trading plan report | DART |
| 2026-06-23 | Officer / major shareholder trading plan report | DART |
| 2026-06-23 | Record date / shareholder register closure set | DART |
| 2026-06-23 | Resolution to convene shareholders meeting | DART |
| 2026-06-23 | Material event report — Capital reduction decision | DART |
| 2026-06-23 | Trading suspension and release | DART |
| 2026-06-19 | Amended: Revenue or profit structure changed materially | DART |
| 2026-06-19 | Amended: Annual report (2026.03) | DART |
| 2026-06-19 | Annual report (2026.03) | DART |
| 2026-06-19 | Audit report submitted | DART |
| 2026-06-12 | Officer / major shareholder ownership report | DART |
Showing the 20 most recent of 40 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.